Found 34 matching trials
CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer PHASE2 This randomized phase II trial studies how well glycosylated recombinant hu...
Show More Location
UC San Diego Moores Cancer Center
Learn More & Join Trial
177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer PHASE1 This phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostat...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy PHASE3 Provenge is an investigational product designed to activate a man's own ant...
Show More Location
South Orange County Urological
Learn More & Join Trial
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T PHASE2 A multicenter, open-label, prospective study to investigate immune boost re...
Show More Location
Arizona Urology Specialists
Learn More & Join Trial
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer PHASE2 The main purpose of this study was to determine whether ADT started before ...
Show More Location
Urology Center of Alabama
Learn More & Join Trial
Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer PHASE2 The purpose of this study is to find out what effects taking ipilimumab, as...
Show More Location
University of California San Francisco
Learn More & Join Trial
Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T PHASE2 This is a clinical research study of an investigational (FDA IND-BB 10091) ...
Show More Location
The Rogosin Institute
Learn More & Join Trial
Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer PHASE2 This is a randomized, double blind, multi-institutional phase II therapeuti...
Show More Location
University of Illinois Medical Center
Learn More & Join Trial
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer PHASE2 This randomized phase II trial studies how well giving sipuleucel-T with or...
Show More Location
City of Hope Medical Center
Learn More & Join Trial
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer PHASE2 This randomized phase II trial studies how well sipuleucel-T with or withou...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial